Medical News

Petrochemical pollution ‘tied to childhood respiratory disease’ Posted: 30 Mar 2009 05:00 PM PDT Children who are exposed to airborne pollution from petrochemical plants are at increased risk for developing asthma, respiratory symptoms, and poor lung function, research suggests.

Traffic exposure linked to impaired lung function in adults Posted: 30 Mar 2009 05:00 PM PDT Daily exposure to traffic-generated air pollution is associated with impaired lung function in adults with asthma and rhinitis, US research shows.

Impaired load/capacity during COPD exacerbation Posted: 30 Mar 2009 05:00 PM PDT There is a significant imbalance between the decreased capacity of the respiratory muscles to generate pressure and increased respiratory load during the early phases of an acute exacerbation of chronic obstructive pulmonary disease, research shows.

Bone marrow stem cells may benefit heart attack patients Posted: 29 Mar 2009 05:00 PM PDT Patients who have suffered a heart attack may benefit from treatment with their own bone marrow stem cells to improve blood circulation within the heart, US study results suggest.

Novel test may predict spread of breast cancer Posted: 29 Mar 2009 05:00 PM PDT Researchers have developed a novel test that they believe indicates the likelihood of a breast cancer spreading to other parts of a patient's body.

Gene mutations linked to poor lung development in children Posted: 29 Mar 2009 05:00 PM PDT Mutations in a gene called SOD3 may cause poor lung development in children and increase their risk of developing conditions such as chronic obstructive pulmonary disease in later life, say researchers.

Panic disorder increases suicide risk in bipolar patients Posted: 29 Mar 2009 05:00 PM PDT Among patients with bipolar disorder, the presence of co-occurring panic disorder is associated with an increased risk of suicide, results of a review show.

JUPITER trial: Rosuvastatin cuts venous thromboembolism risk by 43% Posted: 29 Mar 2009 05:00 PM PDT The lipid-lowering drug rosuvastatin nearly halves the risk for symptomatic venous thromboembolism in apparently healthy people, a new analysis of the JUPITER (Justification for the Use of statins in Primary prevention: an Intervention Trial Evaluating Rosuvastatin) trial has found.

PROTECT AF: WATCHMAN device rivals warfarin in AF Posted: 29 Mar 2009 05:00 PM PDT A novel implantable device might be a worthy alternative to blood thinners in patients with nonvalvular atrial fibrillation, according to the results of the prospective, randomized PROTECT AF trial.

<i>PALB2</i> mutations associated with breast cancer susceptibility in Chinese women Posted: 29 Mar 2009 05:00 PM PDT Two protein-truncating mutations in PALB2 are present in some BRCA1/2-negative Chinese women with early onset breast cancer, a study shows.

Mutations in <i>GPIHBP1</i> may explain some cases of chylomicronemia Posted: 29 Mar 2009 05:00 PM PDT Mutations in the glycosylphosphatidylinositol-anchored high-density lipoprotein–binding protein 1 gene may be responsible for some cases of chylomicronemia, report researchers.

Low LDL cholesterol and hsCRP achieves best CVD risk improvement Posted: 29 Mar 2009 05:00 PM PDT A subanalysis of data from the JUPITER trial shows that reduction in both low-density lipoprotein cholesterol and high-sensitivity C-reactive protein, obtained using rosuvastatin treatment, produces the optimum reduction in cardiovascular disease risk.

Relaxin gives dyspnea relief in acute HF Posted: 29 Mar 2009 05:00 PM PDT Results of a Phase II trial show that the hormone relaxin can relieve dyspnea in patients with acute heart failure and normal-to-increased blood pressure.

Insulin treated diabetics have increased risk for road traffic accidents Posted: 29 Mar 2009 05:00 PM PDT A survey of the Norwegian population has shown that insulin treated diabetics have a slightly higher risk for road traffic accidents involving personal injuries than nondiabetics and diabetics treated with oral blood glucose-lowering drugs.

Increased calcium and magnesium intake linked with lower diabetes risk Posted: 29 Mar 2009 05:00 PM PDT Recent findings from the Shanghai Women's Health study show an apparent protective effect of calcium and magnesium against Type 2 diabetes risk.

Relaxin gives dyspnea relief in acute HF Posted: 29 Mar 2009 05:00 PM PDT Results of a Phase II trial show that the hormone relaxin can relieve dyspnea in patients with acute heart failure and normal-to-increased blood pressure.

HORIZONS-AMI: Stent thrombosis predictors revealed Posted: 29 Mar 2009 05:00 PM PDT Predictors of early and late stent thrombosis after percutaneous coronary intervention (PCI) for ST-elevation myocardial infarction vary, according to the latest findings from the Harmonizing Outcomes with Revascularization and Stents in Acute Myocardial Infarction trial.

TIPS results provide support for polypill Posted: 29 Mar 2009 05:00 PM PDT A polypill combining a statin, aspirin, and three antihypertensive agents may be at least as effective for primary prevention of cardiovascular disease events as each of the drugs taken separately, results of a randomized trial suggest.

Quadruple screening best for mammogram review Posted: 18 Mar 2009 05:00 PM PDT Radiographers can help examine screening mammograms, say Dutch researchers who believe their study may help hospitals with a shortage of screening radiologists.

Novel agent speeds recovery from profound neuromuscular blockade Posted: 08 Jan 2009 04:00 PM PST Sugammadex is markedly faster than an acetylcholinesterase inhibitor at reversing profound rocuronium neuromuscular blockade, a randomized trial shows.

Pre-operative briefings cut OR delays by nearly a third Posted: 08 Jan 2009 04:00 PM PST Pre-operative team briefings reduce the frequency of communication breakdowns that lead to operating room delays, say researchers.

You are subscribed to email updates from MedWire Medical News Combined Feed To stop receiving these emails, you may unsubscribe now.	Email delivery powered by Google
Inbox too full? Subscribe to the feed version of MedWire Medical News Combined Feed in a feed reader.
If you prefer to unsubscribe via postal mail, write to: MedWire Medical News Combined Feed, c/o Google, 20 W Kinzie, Chicago IL USA 60610